Showing results (1731-1740 of 2,534) with videos related to
Sort By:
Pageof 254
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 27, 2019
Anti-MAG IgM: differences in antibody tests and correlation with clinical findingsSabrina Matà, Stefano Ambrosini, Domenica Saccomanno, et al.Pediatric Research|February 7, 2004
A new mitochondrial DNA mutation in ND3 gene causing severe Leigh syndrome with early lethalityMarco Crimi, Alexandros Papadimitriou, Sara Galbiati, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2012
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosisAaron E Miller, Paul O'Connor, Jerry S Wolinsky, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2005
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosisGiovanni Luigi Mancardi, Alessandra Murialdo, Paolo Rossi, et al.Thyroid : Official Journal of the American Thyroid Association|February 5, 2025
Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort StudyGiada Cosentino, Giulia Lanzolla, Simone Comi, et al.Frontiers in Genetics|June 17, 2022
Case Report: Rare Homozygous RNASEH1 Mutations Associated With Adult-Onset Mitochondrial Encephalomyopathy and Multiple Mitochondrial DNA DeletionsArianna Manini, Leonardo Caporali, Megi Meneri, et al.Multiple Sclerosis and Related Disorders|April 17, 2015
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS)B O Khatri, J Pelletier, L Kappos, et al.Neurology|September 26, 2008
Cognitive impairment and structural brain damage in benign multiple sclerosisM Rovaris, G Riccitelli, E Judica, et al.Journal of Neurology|September 26, 2020
Kinematic but not clinical measures predict falls in Parkinson-related orthostatic hypotensionAndrea Sturchio, Alok K Dwivedi, Luca Marsili, et al.The Lancet. Neurology|February 17, 2016
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trialJeffrey A Cohen, Douglas L Arnold, Giancarlo Comi, et al.Pageof 254